Correlation Engine 2.0
Clear Search sequence regions


  • capybara (6)
  • cat (1)
  • IL 10 (1)
  • lipid (5)
  • mice (1)
  • obese mice (4)
  • oil (6)
  • renal fibrosis (1)
  • renal function (1)
  • rodentia (1)
  • TGF β (1)
  • TNF α (1)
  • Sizes of these terms reflect their relevance to your search.

    Obesity is an inflammatory disease associated with secondary diseases such as kidney disease, which can cause lipotoxicity, inflammation and loss of organ function. Polyunsaturated fatty acids act in the production of lipid mediators and have anti-inflammatory characteristics. In this work, the objective was to evaluate renal histopathology in obese mice and the effects of treatment with capybara oil (CO) (5000 mg/kg/day for 4 weeks). Parameters such as body mass, lipid profile, systolic blood pressure, urinary creatinine and protein excretion, structure and ultrastructure of the renal cortex, fibrosis, tissue inflammation and oxidative stress were analyzed. CO treatment in obese mice showed improvement in the lipid profile and reduction in systolic blood pressure levels, in addition to beneficial remodeling of the renal cortex. Our data demonstrated that CO decreased inflammation, oxidative stress and renal fibrosis, as evidenced by quantifying the expression of TNF-α, IL-10, CAT, SOD, α-SMA and TGF-β. Although treatment with CO did not show improvement in renal function, ultrastructural analysis showed that the treatment was effective in restoring podocytes and pedicels, with restructuring of the glomerular filtration barrier. These results demonstrate, for the first time, that treatment with CO is effective in reducing kidney damage, being considered a promising treatment for obesity.

    Citation

    Priscila G Pereira, Luciana L Alves, Bianca T Ciambarella, Kíssila Rabelo, Ana Lúcia R Nascimento, Alan Cesar N Moraes, Andressa Bernardi, Fernanda V Guimarães, Gabriela M Carvalho, Jemima F R da Silva, Jorge J de Carvalho. Capybara Oil Improves Renal Pathophysiology and Inflammation in Obese Mice. Nutrients. 2023 Jun 28;15(13)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37447251

    View Full Text